Financial Advocates Investment Management’s VistaGen Therapeutics VTGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-770
| Closed | -$2.88K | – | 773 |
|
2023
Q1 | $2.88K | Hold |
770
| – | – | ﹤0.01% | 734 |
|
2022
Q4 | $2.38K | Buy |
+770
| New | +$2.38K | ﹤0.01% | 747 |
|
2022
Q3 | – | Sell |
-770
| Closed | -$20K | – | 834 |
|
2022
Q2 | $20K | Hold |
770
| – | – | ﹤0.01% | 673 |
|
2022
Q1 | $29K | Hold |
770
| – | – | ﹤0.01% | 716 |
|
2021
Q4 | $45K | Hold |
770
| – | – | ﹤0.01% | 752 |
|
2021
Q3 | $63K | Buy |
+770
| New | +$63K | ﹤0.01% | 731 |
|
2021
Q2 | – | Sell |
-770
| Closed | -$49K | – | 821 |
|
2021
Q1 | $49K | Hold |
770
| – | – | ﹤0.01% | 723 |
|
2020
Q4 | $45K | Hold |
770
| – | – | ﹤0.01% | 702 |
|
2020
Q3 | $16K | Hold |
770
| – | – | ﹤0.01% | 614 |
|
2020
Q2 | $12K | Hold |
770
| – | – | ﹤0.01% | 586 |
|
2020
Q1 | $10K | Hold |
770
| – | – | ﹤0.01% | 469 |
|
2019
Q4 | $16K | Hold |
770
| – | – | ﹤0.01% | 506 |
|
2019
Q3 | $25K | Hold |
770
| – | – | ﹤0.01% | 479 |
|
2019
Q2 | $17K | Hold |
770
| – | – | ﹤0.01% | 463 |
|
2019
Q1 | $30K | Hold |
770
| – | – | ﹤0.01% | 454 |
|
2018
Q4 | $35K | Buy |
+770
| New | +$35K | ﹤0.01% | 418 |
|
2018
Q3 | – | Sell |
-770
| Closed | -$32K | – | 526 |
|
2018
Q2 | $32K | Hold |
770
| – | – | ﹤0.01% | 482 |
|
2018
Q1 | $21K | Buy |
+770
| New | +$21K | ﹤0.01% | 482 |
|